| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
|
Cell
|
1989
|
6.66
|
|
2
|
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
|
J Immunol
|
1990
|
5.26
|
|
3
|
Cellular and developmental properties of fetal hematopoietic stem cells.
|
Cell
|
1990
|
2.83
|
|
4
|
Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.
|
Mol Cell Biol
|
1990
|
2.25
|
|
5
|
Interleukin-3 supports growth of mouse pre-B-cell clones in vitro.
|
Nature
|
1984
|
1.76
|
|
6
|
Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors.
|
Proc Natl Acad Sci U S A
|
1985
|
1.75
|
|
7
|
Phage display mutagenesis of the chimeric dual cytokine receptor agonist myelopoietin.
|
Leukemia
|
2001
|
1.40
|
|
8
|
Mapping cell surface antigens on mouse pre-B cell lines.
|
Eur J Immunol
|
1985
|
1.29
|
|
9
|
Immunoglobulin lambda light-chain-related genes 14.1 and 16.1 are expressed in pre-B cells and may encode the human immunoglobulin omega light-chain protein.
|
Proc Natl Acad Sci U S A
|
1989
|
1.29
|
|
10
|
B cell subsets and differential responses to mitogens.
|
Immunol Rev
|
1982
|
1.26
|
|
11
|
Cell surface antigens expressed by subsets of pre-B cells and B cells.
|
J Immunol
|
1984
|
1.26
|
|
12
|
Differentiation of murine B cell precursors in agar culture. Frequency, surface marker analysis and requirements for growth of clonable pre-B cells.
|
Eur J Immunol
|
1984
|
1.18
|
|
13
|
Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
|
Blood
|
1996
|
0.98
|
|
14
|
Biochemical and immunological properties of cytokines conjugated to dendritic polymers.
|
Biomed Microdevices
|
2004
|
0.88
|
|
15
|
Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia.
|
Blood
|
1996
|
0.86
|
|
16
|
Ontogeny of murine B-cell responses to thymus-independent trinitrophenyl antigens.
|
Cell Immunol
|
1979
|
0.86
|
|
17
|
Activation and growth of colony-stimulating factor-dependent cell lines is cell cycle stage dependent.
|
J Exp Med
|
1987
|
0.86
|
|
18
|
The immune response in NZB mice of different ages to thymus-dependent and thymus-independent phosphorylcholine antigens.
|
Immunology
|
1978
|
0.85
|
|
19
|
Monoclonal antibodies specific for novel murine cell surface markers define subpopulations of germinal center cells.
|
Cell Immunol
|
1992
|
0.85
|
|
20
|
Polymorphism of Fc receptor on murine B cells is Igh-linked.
|
J Exp Med
|
1985
|
0.84
|
|
21
|
B cell heterogeneity. I. A study of B cell subpopulations involved in the reconstitution of an X-linked immune defect of B cell differentiation.
|
J Immunol
|
1979
|
0.84
|
|
22
|
Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation.
|
Am J Respir Crit Care Med
|
1996
|
0.83
|
|
23
|
Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
|
Blood
|
2000
|
0.83
|
|
24
|
Transformation of B and non-B cell lines with the 2,4,6,-trinitrophenyl (TNP)-specific immunoglobulin genes.
|
Eur J Immunol
|
1985
|
0.82
|
|
25
|
Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
|
Stem Cells
|
2001
|
0.82
|
|
26
|
Delineation of tolerance-sensitive and tolerance-insensitive B cells in normal and immune defective mice.
|
J Immunol
|
1980
|
0.81
|
|
27
|
Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties.
|
Exp Hematol
|
1999
|
0.80
|
|
28
|
Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.
|
Proc Natl Acad Sci U S A
|
1995
|
0.80
|
|
29
|
Circular permutation of granulocyte colony-stimulating factor.
|
Biochemistry
|
1999
|
0.79
|
|
30
|
The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling.
|
J Biol Chem
|
1997
|
0.79
|
|
31
|
Progenipoietins: biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor.
|
Exp Hematol
|
2001
|
0.78
|
|
32
|
Idiotype-specific tolerance: preferential alteration of idiotype expression after neonatal exposure to tolerogen.
|
J Immunol
|
1980
|
0.78
|
|
33
|
Cytokine production by T helper cell subpopulations during prolonged in vitro stimulation.
|
Immunol Lett
|
1991
|
0.78
|
|
34
|
Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
|
Biochemistry
|
1999
|
0.78
|
|
35
|
A single dose of pegylated leridistim significantly improves neutrophil recovery in sublethally irradiated rhesus macaques.
|
Stem Cells
|
2001
|
0.77
|
|
36
|
Structure and expression of the T cell receptor gamma locus in pre-B and early hemopoietic cells.
|
Eur J Immunol
|
1989
|
0.77
|
|
37
|
Secondary structure of human interleukin-3.
|
Int J Biochem
|
1991
|
0.77
|
|
38
|
Phage presentation and affinity selection of a deletion mutant of human interleukin-3.
|
Appl Biochem Biotechnol
|
1997
|
0.76
|
|
39
|
Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
|
Exp Hematol
|
2001
|
0.76
|
|
40
|
Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
|
Exp Hematol
|
1999
|
0.75
|
|
41
|
Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells.
|
Leukemia
|
2001
|
0.75
|
|
42
|
Receptor binding kinetics of human IL-3 variants with altered proliferative activity.
|
Biochem Biophys Res Commun
|
2001
|
0.75
|
|
43
|
Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
|
Exp Hematol
|
2001
|
0.75
|
|
44
|
Immune modifying effects of misoprostol and natural prostaglandins.
|
Br J Rheumatol
|
1991
|
0.75
|
|
45
|
The dual regulatory role of interleukin 4 is mediated through a direct effect on the target cell.
|
Exp Hematol
|
1990
|
0.75
|
|
46
|
Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates.
|
Biol Blood Marrow Transplant
|
1999
|
0.75
|
|
47
|
Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3 dependent cell line.
|
Oncogene Res
|
1991
|
0.75
|
|
48
|
The combined administration of daniplestim and Mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression.
|
Stem Cells
|
1998
|
0.75
|
|
49
|
B-cell subsets: functional and structural characteristics.
|
Crit Rev Immunol
|
1985
|
0.75
|
|
50
|
Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates.
|
Stem Cells
|
2001
|
0.75
|
|
51
|
Modulation of the binding affinity of myelopoietins for the interleukin-3 receptor by the granulocyte colony-stimulating factor receptor agonist.
|
Biochemistry
|
2001
|
0.75
|
|
52
|
The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist.
|
Leukemia
|
2002
|
0.75
|